← All Sponsors
SPONSOR

SCRI Development Innovations, LLC

Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Colon CancerRectal CancerColorectal CancerColorectal Cancer (CRC)Breast Cancer
NCT07011576 Phase 2
Recruiting

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)

Colon Cancer
United States View Trial →
NCT05748834 Phase 2
Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Breast Cancer
United States View Trial →